239 related articles for article (PubMed ID: 2894704)
21. Discriminative stimulus properties of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH DPAT).
Glennon RA
Pharmacol Biochem Behav; 1986 Jul; 25(1):135-9. PubMed ID: 2944129
[TBL] [Abstract][Full Text] [Related]
22. The behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice.
Yamada J; Sugimoto Y; Horisaka K
Eur J Pharmacol; 1988 Sep; 154(3):299-304. PubMed ID: 2976671
[TBL] [Abstract][Full Text] [Related]
23. The long-term effects of 8-hydroxy-2-(di-n-propyl-amino)tetralin (8-OH-DPAT) on copulatory and exploratory behaviour in male rats.
Johansson CE; Meyerson BJ; Höglund AU
Eur J Pharmacol; 1990 Mar; 178(1):1-9. PubMed ID: 2139613
[TBL] [Abstract][Full Text] [Related]
24. Opiate antagonists inhibit feeding induced by 8-OH-DPAT: possible mediation in the nucleus accumbens.
Fletcher PJ
Brain Res; 1991 Sep; 560(1-2):260-7. PubMed ID: 1836972
[TBL] [Abstract][Full Text] [Related]
25. Changes in exploratory behaviour of hamsters following treatment with 8-hydroxy-2-(di-n-propylamino)tetralin.
Buhot MC; Rage P; Segu L
Behav Brain Res; 1989 Nov; 35(2):163-79. PubMed ID: 2530993
[TBL] [Abstract][Full Text] [Related]
26. Evidence that central 5-hydroxytryptaminergic neurones are involved in the anxiolytic activity of buspirone.
Carli M; Prontera C; Samanin R
Br J Pharmacol; 1989 Apr; 96(4):829-36. PubMed ID: 2568143
[TBL] [Abstract][Full Text] [Related]
27. Involvement of 5-HT1A- and alpha 2-receptors in the decreased 5-hydroxytryptamine release and metabolism in rat suprachiasmatic nucleus after intravenous 8-hydroxy-2-(n-dipropylamino) tetralin.
Marsden CA; Martin KF
Br J Pharmacol; 1986 Oct; 89(2):277-86. PubMed ID: 2430656
[TBL] [Abstract][Full Text] [Related]
28. Failure of central 5-hydroxytryptamine depletion to alter the effect of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on timing performance on the free-operant psychophysical procedure.
Body S; Chiang TJ; Mobini S; Ho MY; Bradshaw CM; Szabadi E
Psychopharmacology (Berl); 2001 Nov; 158(3):305-13. PubMed ID: 11713621
[TBL] [Abstract][Full Text] [Related]
29. A single dose of 8-OH-DPAT reduces raphe binding of [3H]8-OH-DPAT and increases the effect of raphe stimulation on 5-HT metabolism.
Beer M; Kennett GA; Curzon G
Eur J Pharmacol; 1990 Mar; 178(2):179-87. PubMed ID: 1691712
[TBL] [Abstract][Full Text] [Related]
30. Median raphe, but not dorsal raphe, application of the 5-HT1A agonist 8-OH-DPAT stimulates rat motor activity.
Hillegaart V; Hjorth S
Eur J Pharmacol; 1989 Jan; 160(2):303-7. PubMed ID: 2527161
[TBL] [Abstract][Full Text] [Related]
31. Low doses of the putative serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicit feeding in the rat.
Dourish CT; Hutson PH; Curzon G
Psychopharmacology (Berl); 1985; 86(1-2):197-204. PubMed ID: 3161115
[TBL] [Abstract][Full Text] [Related]
32. A pharmacological analysis of the eating response induced by 8-OH-DPAT injected into the dorsal raphé nucleus reveals the involvement of a dopaminergic mechanism.
Fletcher PJ; Davies M
Psychopharmacology (Berl); 1990; 100(2):188-94. PubMed ID: 2137632
[TBL] [Abstract][Full Text] [Related]
33. Region-selective inhibition of male rat sexual behavior and motor performance by localized forebrain 5-HT injections: a comparison with effects produced by 8-OH-DPAT.
Hillegaart V; Ahlenius S; Larsson K
Behav Brain Res; 1991 Feb; 42(2):169-80. PubMed ID: 1829365
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat.
Calogero AE; Bagdy G; Szemeredi K; Tartaglia ME; Gold PW; Chrousos GP
Endocrinology; 1990 Apr; 126(4):1888-94. PubMed ID: 2156670
[TBL] [Abstract][Full Text] [Related]
35. Behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in monkeys.
Mizuta E; Yamaguchi M; Kuno S
Eur J Pharmacol; 1990 Mar; 178(1):125-7. PubMed ID: 2139614
[TBL] [Abstract][Full Text] [Related]
36. Characterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepam.
Moser PC; Tricklebank MD; Middlemiss DN; Mir AK; Hibert MF; Fozard JR
Br J Pharmacol; 1990 Feb; 99(2):343-9. PubMed ID: 1970269
[TBL] [Abstract][Full Text] [Related]
37. Effect of chronic treatment with 8-OH-DPAT in the forced swimming test requires the integrity of presynaptic serotonergic mechanisms.
Cervo L; Samanin R
Psychopharmacology (Berl); 1991; 103(4):524-8. PubMed ID: 1829537
[TBL] [Abstract][Full Text] [Related]
38. Partial postsynaptic 5-HT1A agonist properties of the novel stereoselective 8-OH-DPAT analogue (+)cis-8-hydroxy-1-methyl-2-(di-n-propylamino)tetralin, (+)ALK-3.
Hjorth S; Sharp T; Hacksell U
Eur J Pharmacol; 1989 Nov; 170(3):269-74. PubMed ID: 2533557
[TBL] [Abstract][Full Text] [Related]
39. The 5-HT 1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo.
Hjorth S; Magnusson T
Naunyn Schmiedebergs Arch Pharmacol; 1988 Nov; 338(5):463-71. PubMed ID: 2469021
[TBL] [Abstract][Full Text] [Related]
40. 8-OH-DPAT elicits gnawing, and eating of solid but not liquid foods.
Fletcher PJ
Psychopharmacology (Berl); 1987; 92(2):192-5. PubMed ID: 2955445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
